title: Failure of recombinant interleukin-2 to augment the primary humoral response to a recombinant hepatitis B vaccine in healthy adults.
authors.forename: R M
authors.initials: RM
authors.lastname: Rose
authors.forename: J
authors.initials: J
authors.lastname: Rey-Martinez
authors.forename: C
authors.initials: C
authors.lastname: Croteau
authors.forename: R C
authors.initials: RC
authors.lastname: Silvestri
authors.forename: K
authors.initials: K
authors.lastname: Haley
authors.forename: J
authors.initials: J
authors.lastname: DePamphilis
authors.forename: G R
authors.initials: GR
authors.lastname: Siber
mesh_terms: D000328:Adult; D005260:Female; D006510:Hepatitis B Antibodies / Q000096:biosynthesis*; D017325:Hepatitis B Vaccines; D006801:Humans; D007376:Interleukin-2 / Q000276:immunology*; D008297:Male; D011994:Recombinant Proteins / Q000276:immunology; D016037:Single-Blind Method; D014614:Vaccines, Synthetic / Q000276:immunology; D014761:Viral Hepatitis Vaccines / Q000276:immunology*
chemical_list: D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D007376:Interleukin-2; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines